1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • May 2016
  • -
  • BCC Research
  • -
  • 230 pages

Summary

Table of Contents

This BCC Research report covers the key diseases of women’s health market, key growth areas and quantitative market projections for services and devices. Forecast provided through 2020.

Use this report to:

Analyze the historical and current population under treatment for women’s health disordersby regional markets.
Identify and evaluate the impact of demographic, economic and other factors that will drive future demand for women’s health therapeutics market.
Identify promising new drugs and therapies in the development and testing stage and assess the probability of their success.
Identify more accurately leading drug manufacturers and analyze the structure of the women’s health therapeutics industry.

Highlights

The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020.
The U.S. dominated the women’s health therapeutics market and will grow from nearly $19.5 billion in 2015 to $25.3 billion by 2020, rising at a CAGR of 5.4%.
The European market is expected to increase from nearly $11.4 billion in 2015 to $13.0 billion by 2020 with a CAGR of 2.7%.

INTRODUCTION

Women’s health disorders include health issues unique and specific to the female gender. Women’s health concerns have gained significant attention in recent times due to disease pattern (illness, symptoms and response) and treatment differences between men and women. Gynecological, cancer and musculoskeletal disorders are considered the key areas of focus within the women’s health disorder market.

Menopause, postmenopausal osteoporosis, endometriosis, breast cancer and polycystic ovary syndrome (PCOS) are the most common issues within women’s health.

Menopause is one of the most common stages of the natural or surgically induced cessation of estradiol and progesterone production by the ovaries. It is also a major risk factor for the development of osteoporosis. PCOS is also another common endocrine disorder in women of reproductive age.

Endometriosis is a chronic inflammatory disease observed in women of reproductive age. Women have a lifetime risk of one in three of developing cancer. Breast cancer is a growing concern due to the significant numbers of women involved.

Postmenopausal osteoporosis is another known women’s health disorder across the globe. It is also known as type I osteoporosis and affects women 45 to 50 years old and above who have gone through menopause. Attention to women’s health disorders has increased dramatically in the past few decades, expanding from a focus on reproductive care to a new, comprehensive life span approach.

STUDY BACKGROUND

Worldwide, an estimated 300 million females suffer from a women’s health disorder. However, only 25 million to 30 million female patients are actively receiving treatment (e.g., hormone therapy/drugs), primarily due to poor diagnosis of the diseases and lack of awareness. There are a few diseases, such as endometriosis, where the cause of the disease is unknown and thus its treatment remains an intensely debated subject among physicians and patients. There are several treatment options available to obtain relief from the symptoms of endometriosis but there is no cure.

Because of the large patient pool of women’s health disorders, there is a pressing need to develop an up-to-date base of market information to better understand the dynamics of the women’s health therapeutics, technologies and global markets.

This report is the second edition to cover the key diseases of women’s health market, key growth areas and quantitative market projections for services and devices.

Increasing prevalence and the rising concern of patients toward their health is boosting the women’s health market. This study attempts to provide the reader the information and analysis needed to deal with these challenges.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Targeted Therapy Market in the UK

  • April 2017
    77 pages
  • Therapy  

    Targeted Therap...  

    Digestive Syste...  

  • United Kingdom  

View report >

Cranberry Industry

  • April 2017
    6 pages
  • Cranberry  

View report >

Hepatitis Treatment Market in the UK

  • April 2017
    15 pages
  • Hepatitis Treat...  

    Antiviral  

    HIV Antiviral  

  • United Kingdom  

View report >

Diabetes Statistics

12 days ago

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.